Tuesday 18 February 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Pliant Therapeutics
A clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024
Pharmaceutical
The week in pharma: action, reaction and insight – week to November 1
3 November 2024

Latest Ones To Watch News

Biotechnology
Investors unsure on Corbus data for potential Padcev rival
17 February 2025
Biotechnology
Bambusa Therapeutics raises $90 million in Series A Financing
17 February 2025
Biotechnology
Allogene leaps on allogeneic CAR-T therapy success
15 February 2025
More ones to watch news >
Reset all filters
Refine Search
Nuvation Bio
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio


Today's issue

Trio named for ABPI code breaches
Pharmaceutical
Trio named for ABPI code breaches
17 February 2025
Biosimilars
FDA and EMA green light Samsung Bioepis’ Prolia and Xgeva copies
17 February 2025
Biosimilars
Formycon drops development of biosimilar FYB206
17 February 2025
Pharmaceutical
Record Danish pharma exports - but drive for more goes on
17 February 2025
Pharmaceutical
GSK’s Penmenvy wins FDA approval
17 February 2025
Biotechnology
Investors unsure on Corbus data for potential Padcev rival
17 February 2025
Pharmaceutical
Pharmsynthez to build a large-scale plant for cancer drug production in Moscow
17 February 2025

Company Spotlight

A clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze